Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

3.00
Delayed Data
As of Jul 31
 -0.02 / -0.66%
Today’s Change
2.26
Today|||52-Week Range
6.13
-32.43%
Year-to-Date
No recent news for Enzo Biochem Inc.

Today’s Trading

Previous close3.02
Today’s open3.02
Day’s range3.00 - 3.09
Volume50,739
Average volume (3 months)251,503
Market cap$138.2M
Dividend yield--
Data as of 4:05pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)-30.43%
Earnings growth (next 5 years)--
Revenue growth (last year)+2.39%
P/E ratioNM
Price/Sales2.13
Price/Book3.59

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc-0.07-2.11%
RKDAArcadia Biosciences ...-0.14-3.20%
QLTIQLT Inc0.000.00%
HTGMHTG Molecular Diagno...-0.45-4.88%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateOctober 13, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$95.9M
Annual profit (last year)-$10.0M
Net profit margin-10.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer, Director &
CAO
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts